SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

Ripple is seeing intense community volatility as the price slips below the psychological one-dollar support level, fueling a heated debate between retail investors holding for long-term utility and critics who view the asset as a failing, over-hyped project. While bulls are leveraging the dip to accumulate more tokens in anticipation of future regulatory clarity, many participants remain deeply skeptical, openly discussing the potential for further downside as they weigh the asset against broader crypto market performance.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is seeing increased volatility as market participants debate the long-term impact of its off-balance-sheet financing arrangements and potential margin compression in the custom AI chip sector. Despite this, the community remains heavily focused on the stock's role as an AI infrastructure leader, with many retail traders actively buying the dip and dismissing recent downward pressure as market-maker manipulation.

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance is seeing intense bullish sentiment fueled by institutional accumulation and the anticipation of critical upcoming catalysts, including revised revenue guidance and pivotal lung cancer data. The community is actively discussing a potential short squeeze as the stock maintains momentum, with many investors viewing current levels as a long-term entry point for a multi-indication oncology leader.

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

Berkshire Hathaway is trending following an impressive Q2 earnings report that showed a significant shift in strategy, as the company moved from being a net seller of stocks to deploying billions into equities and accelerating share buybacks. Community discussion is polarized, with some investors celebrating the shift and the leadership of Greg Abel, while others remain skeptical, citing concerns over the company's valuation, lack of dividends, and the impact of the portfolio's cash-heavy position on long-term growth compared to the broader market.

New Era Energy & Digital, Inc. is an exploration and production company, which engages in selling oil and natural gas products. The company was founded on February 6, 2023 and is headquartered in Midland, TX.

New Era Energy & Digital Inc.

New Era Energy & Digital is trending following a series of infrastructure de-risking milestones, including the acquisition of construction permits for its Texas Critical Data Center project and the expansion of planned capacity. While investors are debating the company's financial burn rate and lack of an announced tenant, the community is focused on the strategic value of its off-grid, behind-the-meter energy assets amidst a broader surge in hyperscaler demand for power.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology is trending as investors aggressively debate the stock's massive upside potential versus concerns about dilution and management credibility ahead of upcoming Q2 earnings. The community is focused on the company's expansion into the sovereign AI infrastructure market and the possibility of a significant short squeeze given the stock's high short interest and small float.

Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.

Trulieve Cannabis Corp - Ordinary Shares (Sub Voting)

Trulieve Cannabis Corp 

Trulieve Cannabis Corp is trending as investors monitor its recent NYSE uplisting alongside active community discussions regarding a share buyback program and the upcoming rescheduling hearings. Market participants are debating the long-term potential of US multi-state operators versus Canadian producers, with many focusing on whether these regulatory catalysts will finally unlock institutional capital and normalize profitability.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is trending amid intense community debate over its aggressive Bitcoin-heavy treasury strategy, with discussions focused on the potential impact of share dilution, regulatory uncertainty, and speculation regarding its long-term viability. Investors remain deeply polarized, balancing institutional accumulation and options-driven bullish sentiment against vocal criticism of management's reliance on secondary offerings.

Strive, Inc. engages in the provision of an asset management Bitcoin treasury. It is focused on maximizing value for shareholders, accumulating bitcoin and outperforming bitcoin over the long run. The company was founded by Arshia Sarkhani, Jackson Fairbanks, Arman Sarkhani, and Kyle Fairbanks on March 9, 2022 and is headquartered in Dallas, TX.

Strive Inc. - Ordinary Shares - Class A

Strive Inc.

Strive Inc. (ASST) is generating intense discussion as investors monitor its capital allocation strategy, specifically the ongoing accumulation of Bitcoin against the dilution of common shares. The community remains sharply divided between bulls focused on the potential yield from its SATA preferred stock and the long-term Bitcoin treasury thesis, and skeptics who are raising concerns about the sustainability of its leverage, high-interest obligations, and the impact of frequent share issuance on shareholder value.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance is gaining positive momentum as investors cheer reports that California Governor Gavin Newsom is pushing for a settlement to resolve antitrust litigation and prevent job losses, while international regulators have already cleared the merger. The community is actively debating the impact of these legal hurdles, the company's commitment to theatrical production volumes, and the potential relocation of operations if the dispute remains unresolved.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

If You Invested $100 In Charles River Stock 15 Years Ago, You Would Have This Much Today

Charles River (NYSE:CRL) has outperformed the market over the past 15 years by 2.07% on an annualized basis producing an average annual return of 15.79%. Currently, Charles River has a market capitalization of $14.32read more...

International Markets and Charles River (CRL): A Deep Dive for Investors

Explore how Charles River's (CRL) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.

ICLR Jumps 33.2% in Three Months as Recovery Expectations Strengthen

ICON's 33.2% rally is backed by stronger proposal flow, bookings and backlog, but weaker earnings and margins cloud the recovery.

CRL Q2 Earnings and Revenues Top, '26 View Up, Stock Up in Pre-Market

Charles River beats Q2 earnings and revenue estimates, raises 2026 outlook and gains 7.9% in pre-market trading.

Has Charles River Laboratories International (CRL) Outpaced Other Medical Stocks This Year?

Here is how Charles River Laboratories (CRL) and Curaleaf Holdings, Inc. (CURLF) have performed compared to their sector so far this year.

Charles River (CRL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Charles River (CRL) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Charles River Laboratories (CRL) Q2 Earnings and Revenues Surpass Estimates

Charles River (CRL) delivered earnings and revenue surprises of +11.03% and +3.43%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Charles River Laboratories International Q2 26 Earnings Conference Call At 9:00 AM ET

(RTTNews) - Charles River Laboratories International Inc. (CRL) will host a conference call at 9:00 AM ET on August 5, 2026, to discuss Q2 26 earnings results...

Charles River Laboratories Announces Second-Quarter 2026 Results

Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the second quarter ended June 27, 2026. Key Highlights Reports second-quarter revenue of $1.00 billion, GAAP loss per share of $(0.03), and non-GAAP earnings per share of $3.02. Organic revenue growth of 0.1...

Can These 3 MedTech Stocks Hit Targets This Earnings Season?

Can Zimmer Biomet, Charles River Laboratories and Bio-Techne meet earnings expectations? See the MedTech trends and company-specific drivers in focus.

Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. The Research Models and Services segment includes its insourcing solutions business and Charles River accelerator and development lab footprint. The Discovery and Safety Assessment segment offers regulatory-required safety testing of potential new drugs, vaccines, industrial and agricultural chemicals, consumer products, veterinary medicines, and medical devices. The Manufacturing Solutions segment focuses on microbial solutions and biologics solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.

Charles River Laboratories International Inc.

Charles River Labs Stock Soars On Strategic Review Plan With Elliott: Retail Investors Optimistic

Equity

Bullish Sentiment

Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is headed towards a winning week. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '26	$2.96	--	--	N/A
Q2 '26	$2.74	$3.02	10.14%	BEAT
Q1 '26	$1.94	$2.06	6.00%	BEAT
Q4 '25	$2.34	$2.39	1.98%	BEAT
Q3 '25	$2.34	$2.43	3.95%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q2 '26

Historical Earnings